Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Intervention With Zoledronate to Prevent Bone Complications in Pediatric HSCT Survivors
NCT07375290Phase 1Recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jul 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of zoledronate in osteoporosis, sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Safety of early intervention Zoledronate at 60 days and Feasibility of early intervention Zoledronate at 1 week. Started Jul 2026; status: recruiting.
02
Drugs
zoledronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07375290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07375290.